← All organizations
China National Biotec Group Co., Ltd
For profit
Also known as: China National Biotec Group Company | China National Biotec Group Company Limited | China National Biotec Group Company ltd | Co., Ltd Shanghai Institute Of Biological Products | Lanzhou Institute of Biological Products Co., Ltd | Shanghai Institute Of Biological Products | SINOPHARM
Highest phase reached
Phase 4
First clinical trial
Jul 1, 2009Last known activity
Dec 31, 2025
Timeline
1930s
- Jun 1, 1934
China National Biotec Group Co., Ltd— Founded
2010s
- Aug 3, 2010
Beijing Doing Biomedical Co., Ltd.— Acquired
- Apr 28, 2017
Drugs by trial phase (81 distinct, 103 trials)
Phase 4 (23 own, 2 via acquisition)
- 23-valent pneumococcal polysaccharide vaccine
- inactivated rabies vaccine
- tivantinib
- hepatitis a vaccine, inactivated
- multi-valent pneumococcal conjugate vaccine
- ev71 vaccine
- inactivated influenza vaccine
- live attenuated chimeric japanese encephalitis vaccine
- live attenuated varicella vaccine
- live oral poliovirus type 1, 2 and 3
- measles-rubella vaccine
- measles, mumps, and rubella vaccine
- inactivated varicella vaccine
- acellular pertussis vaccine (including diptheria and tetanus toxoids)
- bivalent oral polio vaccine (bopv), type 1 and type 3
- +10 more
Phase 3 (17 own, 0 via acquisition)
- paclitaxel
- rimabotulinumtoxinB
- trastuzumab
- Measles, Mumps and Rubella Vaccine, Live
- carboplatin
- bevacizumab
- yellow fever vaccine 17d strain
- Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine
- docetaxel
- rituximab
- haemophilus influenzae type b conjugate vaccine
- recombinant sars-cov-2 vaccine
- bbibp-corv
- omicron covid-19 vaccine (vero cell), inactivated
- bibp omicron inactivated covid-19 vaccine (vero cell)
- +2 more
Phase 2 (14 own, 2 via acquisition)
Phase 1 (18 own, 5 via acquisition)
Indications
Studied for
- Breast Neoplasms
- Caliciviridae Infections
- Chickenpox
- Enterovirus Infections
- Foot-and-Mouth Disease
- Gastroenteritis
- Hand, Foot and Mouth Disease
- Hepatitis
- Hepatitis A
- Herpes Zoster
- Influenza, Human
- Influenza in Birds
- Lymphoma, Large B-Cell, Diffuse
- Meningitis
- Meningitis, Meningococcal
- Migraine Disorders
- Mouth Diseases
- Muscle Spasticity
- Plague
- Pneumococcal Infections
- Pneumonia
- Pneumonia, Pneumococcal
- Poliomyelitis
- Stroke
- Urinary Bladder, Overactive
- Virus Diseases
Subsidiaries (2 direct, 2 total across the full acquisition tree)
Recent trials (50)
- NCT07253675Lead sponsorPhase 2Dec 31, 2025
- NCT07302256Lead sponsorPhase 1Dec 16, 2025
- NCT07205198Lead sponsorPhase 1Sep 30, 2025
- NCT07205198OfficialPhase 1Sep 30, 2025
- NCT07149454Lead sponsorPhase 1Aug 18, 2025
- NCT07106918Lead sponsorEarly Phase 1Aug 17, 2025
- NCT06990464Lead sponsorPhase 1Jun 15, 2025
- NCT06985368Lead sponsorPhase 1Jun 15, 2025
- NCT06932523Lead sponsorPhase 1/Phase 2Jun 1, 2025
- NCT06771479Lead sponsorPhase 1Jan 22, 2025
- NCT06194656Lead sponsorPhase 2Sep 27, 2024
- NCT06512116Lead sponsorPhase 1Jul 23, 2024
- NCT06399003Lead sponsorPhase 3Jun 28, 2024
- NCT06298058Lead sponsorPhase 1May 9, 2024
- NCT06410859Lead sponsorPhase 2Apr 25, 2024
Details
- Founded
- Lanzhou, CN Jun 1, 1934
- Last known activity
- Dec 31, 2025
Notes
--- Pre-folding founded info: 1949-06-01 None None China http://www.siobp.com/english/html/enterprise_intro.html ---